Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06185985
Status:
RECRUITING
Last Update Posted:
2024-03-25
First Post:
2023-12-15
Brief Title:
Open-label Safety and Efficacy of SPN-812 Viloxazine Extended-release Capsule in Adults With ADHD and Mood Symptoms
Sponsor:
Supernus Pharmaceuticals Inc
Organization:
Supernus Pharmaceuticals Inc
Organization Data
Organization:
Supernus Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
812P413
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Supernus Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None